Potlako: A Programmatic Intervention to Improve Access to Timely Oncology Care
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02752061|
Recruitment Status : Recruiting
First Posted : April 26, 2016
Last Update Posted : August 29, 2017
Diagnostic and treatment delays contribute substantially to disparities in cancer morbidity and mortality between low- and middle- income countries (LMICs) and high-income countries. Individuals present with advanced stage disease resulting in minimal chance for cure or long-term survival.
The Potlako project will implement and evaluate a multifaceted intervention to test the hypothesis that a package of enhanced coordination of care including an electronic messaging, transportation support, and training targeted at generalist clinicians at primary and secondary level facilities, can reduce time to diagnosis and stage at diagnosis for HIV-infected individuals with cancer.
|Condition or disease||Intervention/treatment||Phase|
|Neoplasms HIV Healthcare Disparity||Other: Potlako intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||2600 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Potlako: A Programmatic Multi-facility Level Intervention to Improve Access to Timely Oncology Care in Botswana|
|Actual Study Start Date :||April 2016|
|Estimated Primary Completion Date :||April 2019|
|Estimated Study Completion Date :||April 2019|
Experimental: Kweneng East District
Patient presenting with possible cancer symptoms/sign to a clinic or hospital in Kweneng East District during study period.
Other: Potlako intervention
Multicomponent intervention including:
No Intervention: All other districts
Patient presenting with possible cancer symptoms/sign to a clinic or hospital in all other districts of Botswana (or Kweneng East prior to implementation of intervention).
- Cancer stage [ Time Frame: 1 day visit ]
- Time from initial clinic visit with cancer symptom/sign to entry into oncology care [ Time Frame: 1 day visit ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02752061
|Botswana Harvard AIDS Institute||Recruiting|
|Contact: Kerapetse Botebele, RN firstname.lastname@example.org|
|Principal Investigator: Neo Tapela, MD|